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Scalpel or Rays?
Radiotherapy and the Struggle for the Cancer
Patient in Pre-Second World War Germany
TON VAN HELVOORT*
Introduction
Cancer treatment generally comes in four modalities.' Traditionally, surgery of
tumours was the most important, while radiotherapy, chemotherapy and im-
munotherapy were introduced as new forms of treatment in the course of the
twentieth century. Although chemotherapy and immunotherapy did not become
standard until after the Second World War, X-rays and radium were used as
alternatives to the surgical knife in eliminating cancer cells soon after their discovery
at the end ofthe nineteenth century.2 This essay is concerned with the way in which
radiotherapy for the treatment of cancer took shape, especially in Germany, in the
first decades of the twentieth century. The analysis concentrates on two aspects.
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The first is that of the struggle between the representatives oforthodox medicine,
those using the scalpel in the fight against cancer, that is to say, general surgeons,
internists, gynaecologists, dermatologists and oto-laryngologists, and those who
perceived in rays a new, separate form of treatment of the cancer patient, i.e. the
radiotherapists-to-be. When X-rays and radium were found to be effective in the
combat against cancer, radiotherapists sought to create their own niche within the
existing ecology ofmedical professions. In his System ofprofessions, Andrew Abbott
argues that the establishment of a profession is best analysed in terms of tasks,
jurisdiction and competition.3 The present essay illustrates that this "infighting" over
radiotherapy took the form of a struggle for the cancer patient and forjurisdiction
over the use of the new techniques such as X-rays and radium.
The second focus of this essay is the role ofcostly instruments and resources and
their impact on the organization of therapy. X-rays as well as radium could be
deployed as small-scale or large-scale techniques. Their first therapeutic applications
were small-scale, viz, X-ray tubes which had already been used for diagnostics were
now applied therapeutically by merely extending the duration of the application;
radium was used in milligram quantities for superficial tumours. In the 1920s,
however, a breakthrough took place. The X-ray instruments were now operated at
several hundreds of kilovolts, and so-called radium bombs or canons, containing
several grams of radium, were designed for cancer therapy. In addition, more
knowledge was available on the risks accompanying these techniques, for example
those ofskinburns ortumours. Thesespecificconditions stimulatedtheestablishment
oflarge centralized institutes for cancer treatment and cancer research. At the 1926
congress on 'Cancer Control', held at Lake Mohonk, New York, Claude Regaud,
director of the "Therapeutic Service" of the Paris-based Curie Foundation claimed
that the developments outlined above indicated the necessity of:
. . . calling in for the examination and treatment ofpatients, men ofvarious specialties whose
work must be exactly co-ordinated; of placing at the service of diagnosis and treatment
different kinds oflaboratories, all well equipped; ofbringing together special X-ray apparatus
which is numerous, heavy, and costly to purchase and maintain; ofemploying large quantities
ofradium-all this explains adequately the recent organization of anti-cancer therapy with a
view to a work that is to be accomplished by a collective staff, in special, well-endowed
establishments.4
In France, England, Sweden and the United States such centralized cancer institutes
were indeedestablished in thefirstdecades ofthetwentieth century, mainly supported
by huge philanthropic donations. Although even in these specialized establishments
a certain degree of rivalry would have existed between radiotherapists and medical
specialists such as surgeons, intemists and gynaecologists, these institutes were
instrumental in establishing radiotherapy as an independent profession and in the
'Andrew Abbott, The system ofprofessions: and X-Rays?', in American Society for the
an essay on the division ofexpert labor, University Control of Cancer, Cancer control, Chicago,
of Chicago Press, 1988. Surgical Publishing Co., 1927, pp. 116-40, p. 120.
'Claude Regaud, 'What is the value and what
should be the organization and equipment of
institutions for the treatment of cancer by radium
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development of a multi-disciplinary approach to cancer treatment. In Germany,
however, radiotherapy lacked a centralized organization until well after the Second
World War, and fell under thejurisdiction ofvarious specialities such as surgery and
gynaecology.
This delay in the centralization of German radiotherapy has been generally
acknowledged.5 In 1959, the Swiss radiologist Hans R Schinz stated that in the
organization ofradiotherapy "Germany, Rontgen's homeland, hascuriouslydropped
behind".6 And in a discussion of the development of German medical disciplines,
Hans-Heinz Eulner concluded in regard to radiotherapy that the Anglo-Saxon and
Scandinavian countries and Switzerland were quite advanced in the centralization
of radiotherapy while in Germany "the clinicians had opted for the principle of
decentralization".7 Thus, German radiotherapy and specialized cancer institutes
became institutionalized relatively late in comparison to countries such as France,
England, Sweden and the United States.8
The conflicts over the introduction of radiotherapy in Germany are well docu-
mented by archival and published sources, because during the 1930s a struggle
developed over the Institut fur Krebsforschung (Institute for Cancer Research;
hereafter IfK) of the Berlin Charite hospital. At that time, the IfK was led by the
Jew Ferdinand Blumenthal (1870-1941), who had also been deputy head when the
Institute was established in 1903 by Ernst von Leyden. Von Leyden, who had been
a professor of internal medicine in StraBburg before he was appointed head of the
First Medical Clinic of the Charite in 1885, was Germany's leading internist and
became the first director of the IfK. After a period in which the Institute was led
by others, Blumenthal had become director in the mid-1910s, and in the late 1920s
he worked towards the centralization and regulation of German cancer control in
general and of radiotherapy in particular. In this he was supported by the Reichs-
ausschuB fur Krebsbekampfung (State Committee for Cancer Control), which was
inaugurated in 1931, signalling the first definite involvement ofthe German state in
this aspect ofpublic health. Blumenthal's desire for centralization, backed up by the
ReichsausschuB, metwith powerful resistance from other Charite clinics, the medical
faculty of Berlin University and the German societies for surgery and gynaecology.
In the early 1930s, the latter specialists successfully penetrated the ReichsausschuB,
and National Socialist measures against Jews helped to ensure the neutralization of
attempts to centralize radiotherapy in Germany and to establish one or two national
cancer institutes.
Thus, the actual development of radiotherapy in Germany differed from that in
5On German radiotherapy, see Hans-Peter 7Hans-Heinz Eulner, 'Rontgenologie', in idem,
Heilmann, 'Radiation oncology: historical Die Entwicklung der medizinischen Spezialfacher
development in Germany', Int. J. Radiat. OncoL, an den Universitaten des deutschen Sprachgebietes,
Biol., Phys., 1996, 35: 207-17, pp. 207-9. See also Stuttgart, Ferdinand Enke, 1970, pp. 421-6, p.
Heinz Goerke, FzJnfundsiebzig Jahre Deutsche 425.
R&ntgengesellschaft, Stuttgart, Georg Thieme, 'Gustav Wagner and Andrea Mauerberger,
1980, pp. 96-103. Krebsforschung in Deutschland: Vorgeschichte und
6Hans R Schinz, Sechzig Jahre medizinische Geschichte des Deutschen Krebsforschungs-
Radiologie: Probleme und Empirie, Stuttgart, zentrwns, Berlin, Springer, 1989.
Thieme, 1959, p. 223.
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countries such as France, England, Sweden and the USA. It will be argued below
that this was related to the strength of German orthodox specialists, the costly
nature of radium and the lack of German resources for radioactive substances, as
well as to the absence ofa philanthropic tradition with regard to cancer control and
research and the reluctance of the German state to support the latter.9 It must be
admitted that the tension between surgeons and medical specialists on the one hand
and radiotherapists on the other about thejurisdiction over the new cancer treatment
modalities occurred in all countries, but the specifics ofthe German situation made
the disaccord more visible and the consequences more enduring.
Introducing Radiotherapy into Cancer Treatment
In the late nineteenth century, surgery was the standard treatment of cancer and
had achieved a high level of perfection. The possibility of general anaesthesia had
lessened the fear of operations and also allowed them to last longer. Furthermore,
under the influence of the work of Joseph Lister, Louis Pasteur and Robert Koch,
the use of antiseptics and a strictly aseptic protocol had ameliorated mortality and
morbidity.'0 Surgical intervention in cancer was based on the consideration that early
cancer was a local disease and only in a later phase did the tumour cells spread via
the lymph nodes, after which the disease could establish itself in other organs
(metastasis)."
In the first decades ofthe twentieth century, cancer patients constituted a quarter
of the surgeon's patients.'2 For gynaecologists too, the treatment of cancer patients
made up a substantial part oftheir daily activities. Exterior forms ofgynaecological
cancer, e.g. breast cancer, were relatively simple to deal with surgically. In many
cases of cervical cancer, however, the tumour was difficult to access through the
vagina. This mode ofoperation resulted in a high percentage ofrelapses, i.e. patients
in whom the tumour returned or metastasis was not prevented. Difficult cases of
cervical cancer were often approached via the abdominal wall (laparotomy), a major
operation in which the chance of recovery was heavily influenced by the woman's
constitution.'3 In addition to these difficulties, there were many inoperable cases of
cancer patients whose tumours were too large to be removed surgically or had fused
with surrounding organs and tissues. Clearly there was need for an alternative to
the scalpel.
In late 1895, Wilhelm C Rontgen reported that, while workingwith acathode tube,
he had observed a new kind ofrays.'4 These he denoted as "X-rays", to indicate that
9On philanthropy, see Lily E Kay, 12Wolfgang Genschorek, Ferdinand
'Rethinking institutions: philanthropy as an Sauerbruch: ein Lebenfur die Chirurgie, Leipzig, S
historiographic problem of knowledge and Hirzel, 1981, p. 181.
power', Minerva, 1997, 35: 283-93. '3Walter Stoeckel, Erinnerungen eines
'° For the role of surgery in cancer, see, for Frauenarztes, Leipzig, S Hirzel, 1979, pp. 109-10.
instance, George J Hill, II, 'Historic milestones in Gerald L'E Turner, 'Rontgen, Wilhelm
cancer surgery', Semin. Oncol., 1979, 6: 409-27. Conrad', in C C Gillispie (ed.), Dictionary of
" Cf. Charles P Childe, The control ofa scientific biography, vol. 11, New York, Charles
scourge, or, how cancer is curable, New York, E P Scribner's Sons, 1981, pp. 529-31.
Dutton, 1907.
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their nature was still unknown. Rontgen observed that these rays could pass through
the fleshy part ofa handbutwere attenuated by bones. Thevisualization ofthe inside
ofthe body would prove to have an enormous impact on medicine, and even on the
imagemanhadofhimself. 5Withindiagnostics, X-rayswereusedinthreeways,namely
in trauma medicine, bone diseases and fractures, and the search for corpora alienum
such as bullets (Fremdkorpersuche). Therefore, X-ray diagnostics were applied mostly
within surgery, orthopaedics and internal medicine. Each specialism claimed the ap-
plication ofthe X-ray technique to its ownfield ofcompetence.'6
In the early years ofthe twentieth century, the Surgical Clinic as well as the First
and Second Medical Clinics of the Charite obtained their own X-ray departments.
In 1901, the Second Medical Clinic, headed by Friedrich Kraus, got such facilities,
and three years later the First Medical Clinic, headed by Ernst von Leyden, obtained
them too. Furthermore, the Nerve Clinic, the Dermatological Clinic and the Medical
Out-Patient Clinic had their own X-ray equipment installed.'7
Soon after the discovery ofX-rays and their amazing ability to pass through flesh,
a second application was found for them. It was claimed that X-rays had a specific
destructive effect on rapidly dividing tissue cells, especially tumours, compared with
their effect on normal tissue.'8 Because of the problems discussed above in relation
to the surgical treatment of cervical cancer, X-rays were used by the gynaecologist
Bernhard Kronig from Freiburg im Breisgau to treat this disease, with highly
promising results. In 1913 Kronig presented his results at the German Congress of
Gynaecologists in Halle. This congress was a landmark in the application of
radiotherapy to gynaecological cancer.'9 According to the Charite's gynaecologist
Walter Stoeckel, it was a historic occasion because ofthejubilant atmosphere which
spread "right up to the most senior Geheimrate." Prominent gynaecologists such as
Albert Doderlein, Ernst Bumm and Carl Menge argued that if the results reported
at Freiburg were corroborated, they would refuse to use the scalpel any longer.20
For those gynaecologists who tried out radiotherapy, there was no doubt that the
new cancer intervention technique had a valid role to play. Carl J GauB from
Freiburg, one of Kronig's co-workers, and the radiotherapists Hans Meyer from
Kiel and Richard Werner from Heidelberg felt that the time was right for an
independent periodical and in 1912 they established the journal Strahlentherapie
15 Bettyann Holtzmann Kevles, Naked to the
bone: medical imaging in the twentieth century,
New Brunswick, NJ, Rutgers University Press,
1997. This book discusses the impact ofX-rays
on man's self-image and society in general.
16This situation was recently expressed
evocatively as follows: "at the time of their
discovery, radiographs were limited to small glass
plates that reflected the organizational
deconstruction of medicine into specialties-each
concentrating on the anatomical area covered by
one small plate." Ibid., p. 299.
7Kurt-Achim Hinze, 'Aspekte der
Entwicklung der Rontgenologie an der Charite zu
Berlin in den ersten drei Jahrzehnten nach der
Entdeckung der Rontgenstrahlen', PhD thesis,
Humboldt-Universitat Berlin, 1978, pp. 20-33. In
the early 1930s, an attempt was made to unite the
various X-ray departments into one independent
unit, but this endeavour failed.
8The idea that X-rays were selectively more
destructive to tumour cells than to normal cells
was not universally accepted, however; see David
von Hansemann, 'Krebsheilmittel in Theorie und
Praxis', Zeitschriftfiir Krebsforschung, 1914, 14:
139-50, pp. 143-4.
' Hans Meyer, 'Aus der Pionierzeit der
Strahlenheilkunde: ein Lorbeerblatt auf das Grab
von Bernhard Kr6nig, Freiburg i. Br.', Med
Klin., 1955, 50: 65-6, p. 66.
20Stoeckel, op. cit., note 13 above, p. 86.
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(Radiotherapy).2' Werner was the radiotherapist at the Heidelberg Samariterhaus,
established by the surgeon Vincenz Czerny at the beginning ofthe twentieth century.22
Although Czerny was a surgeon, he clearly saw radiotherapy as having an important
role to play in cancer treatment. In a short introductory note to the new journal,
he wrote that under favourable conditions radiotherapy "can even replace the
surgeon's knife. Surgeons, who are constantly overburdened by the many different
demands made on their skills, will welcome being relieved of many thankless tasks.
In fact, surgeons have recently learned to adapt to the needs of radiologists, and
will prepare patients for them by treating open wounds and by dissecting out or
exposing tumours, etc."23 Apparently, Czerny was willing to make surgery secondary
to radiotherapy in the treatment ofcancer, an attitude that was not shared by many
surgeons. Although many cancer patients were in a poor condition already, surgeons
often did not hesitate to burden them with an exhausting operation. Much was at
stake in the competition between surgery and radiotherapy: the status and authority
of surgery with regard to cancer treatment, as well as certain financial interests.
As indicated above, most medical specialists were familiar with the technique of
X-ray diagnostics. The move from X-ray diagnostics to X-ray therapy seemed to be
only a quantitative change. In the early years, for instance, X-ray therapy ofcervical
cancer was performed by the simultaneous application of two X-ray tubes placed
on the abdomen and directed at the cervix, and a third one irradiating the cervix
through the vagina.24
Twoinventions, madeduringtheFirstWorldWar, wouldmakeX-raytherapymuch
more efficient. The first was the "hot-cathode tube" (Gliilkathodenrdhre), which was
developed by William D Coolidge from Schenectady, New York, and the second was
the "cascade transformer". This powerful apparatus necessitated a more efficient do-
simetry in order to prevent serious injuries to the patient.25 Experts tried to solve the
problems ofquantification bygiving aprecisedescription oftheinstrumentsused, i.e.,
the construction of the tube, the electrical power and current applied, and the time
period ofexposure. Radiation was alsoempirically quantified in terms ofthe dose the
skin could withstand, later followed by more precise methods of dosimetry such as
colorimetryandthemeasurementofionizationcausedbytheradiation overaspecified
21 Carl J GauB, Hans Meyer, and Richard
Werner, 'Zur Einfuihrung', Strahlentherapie, 1912,
1: 1-3.
22For a brief history of the cancer institute/
hospital Samariterhaus at Heidelberg, see
Friedrich Voelcker, 'Zur Eroffnung des Institutes
fur experimentelle Krebsforschung in Heidelberg',
Munch. Med Wochenschr., 1906, 53: 1919-21;
and Vinzenz Czerny (ed.), Das Heidelberger
Institutfar experimentelle Krebsforschung I. Teil.
Geschichte, Baubeschreibung, wirtschaftliche
Verhdltnisse, Leistungen des Instituts,
Aktensammlung, Tubingen, H Laupp'schen
Buchhandlung, 1912.
23Vncenz Czerny, 'Die Bedeutung der
Strahlenbehandlung ftir die Chirurgie',
Strahlentherapie, 1912, 1: 4-5, p. 5.
24Kurt Warnekros, 'Zur R6ntgentechnik der
Carcinombestrahlung', Verh. Berlin. med. Ges.
Gesellschaftsjahre 1913, 1914, 44: 416-23, p. 423.
For a discussion of the widespread early use of
radiotherapy in North America, see Charles R R
Hayter, 'The clinic as laboratory: the case of
radiation therapy, 1896-1920', Bull. Hist. Med,
1998, 72: 663-88.
25Unfamiliarity with the effects of radioactive
rays also claimed many victims amongst
radiotherapists themselves. Those who died as a
consequence of immediate or protracted radiation
were included in an Ehrenbuch (Book of honour);
see Hermann Holthusen, Hans Meyer, and
Werner Molineus (eds), Ehrenbuch der
R6ntgenologen und Radiologen aller Nationen,
Munich, Urban & Schwarzenberg, 1959.
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period.26 In addition to X-ray therapy, however, there was a second type ofradiation
used in the treatment oftumours, namely "radium therapy".
Radium Therapy in Germany
In the context of the discovery of X-rays and their presumed relation to phos-
phorescence, Antoine-Henri Becquerel made a study ofuranium salts. During one of
theseexperiments,inearly 1896,hediscoveredanewformofradiation.27Thisdiscovery
was elaborated upon by Marie (Sklodowska-)Curie who used a piezo-electrometer
developed by her husband Pierre Curie to study whether this kind of radiation also
emanated from other elements. She found that thorium compounds gave evidence of
the same property, and this newform ofenergyfromuranium andthoriumshe named
radioactivity. Subsequently she found that pitchblende (uraninite; Uranpecherz) pro-
duced more radioactivity than could beexplained on the basis ofitsuranium content.
Apparently, afurtherradioactivesubstancehadtobepresent,andherresearchresulted
in the isolation of the element polonium, the discovery of which was announced in
July 1898. Subsequently, a second element was isolated, which was named radium
(announced in December 1898) andpossessed 2million times moreradioactivity than
uranium. The fact that one part ofradium had to be isolated from 4 million parts of
pitchblende meant that enormous investments had to be made to isolate enough. At
thattime, theonlyuraniumminewas to befoundinJoachimstal, Bohemia,whichwas
then under the authority ofAustria (it is nowpart ofthe Czech Republic).28
The therapeutic effect ofX-rays on dermatological disorders (for instance, lupus)
stimulated the application ofradium to this kind ofdisease as well.29 The application
of radium to dermatology and benign tumours promptly resulted in striking im-
provements. Radium therapy was even used to heal skin lesions that had resulted
fromX-ray bums. Successwas reportedwithmalignant tumours too. Deeply situated
tumours could be caused to regress by placing tubes containing radium inside the
tumour (interstitial radium implantation).30
Sincethesuppliesofuraniumwerelimited, as aconsequenceofradium'stherapeutic
application, theprice skyrocketed. In 1911, radiumwas found incarnotite (vanadium
oxide) in Colorado (USA), which meant that an important additional source had
become available. In Germany, however, the shortage of radium was dire.
In 1904,theGermanEmperorcommissionedPaulEhrlichtodevotehimselftocancer
research. A few years later, Ehrlich was asked by the Minister ofScience von Trott zu
26Goerke, op. cit., note 5 above, pp. 103-5; 497-503; Jean Wyart, 'Curie, Pierre', in Gillispie
Eisenberg, op. cit., note 2 above, pp. 492-7. See (ed.), op. cit., note 14 above, vol. 3, pp. 503-8;
also Ame Hessenbruch, 'The commodification of see also Eisenberg, op. cit., note 2 above, pp.
radiation: X-ray and radium standards, 43-50.
1896-1928', PhD thesis, Cambridge University, 29Eisenberg, op. cit., note 2 above, pp.
1995. 481-510.
27See, for instance, Alfred Romer, 'Becquerel, 30Ibid., pp. 511-26. See also Bernard Pierquin,
(Antoine-)Henri', in Gillispie (ed.), op. cit., note 'La radiumtherapie de sa naissance a sa mort,
14 above, vol. 1, pp. 558-61. 1896-1976', Cancer Radiotherapie, 1997, 1: 5-13.
28 On the discovery of radium, see Adrienne R For the development of radium dosimetry, see
Weill, 'Curie, Marie (Maria Sklodowska)', in Eisenberg, op. cit., note 2 above, pp. 523-5, and
Gillispie (ed.), op. cit., note 14 above, vol. 3, pp. Hessenbruch, op. cit., note 26 above.
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Solz to report on the availability ofradium in Germany for the treatment ofcancer.3'
Ehrlich argued that onemetric ton of Uranpecherz ofthe bestqualityyielded only 0.2
grams ofradium. The ore from Joachimstal had this quality and the French also had
a radium production facility at Nogent-sur-Marne. The only German producer was
Buchler & Co. at Braunschweig, and the only German uranium ore was mined at
Kreuznach, Bad Dtirkheim and Baden-Baden, but it was of a much lower grade.
German scientists did manage to find an alternative for radium, however. From the
residues of the production of thorium for gas mantles, the radioactive substance
mesothorium could be extracted, whichwas also useful forradiotherapy.32
In a 1909 letter to the German Emperor, von Trott zu Solz presented an outline of
the distressing situation regarding the availability ofradium for cancer treatment in
Germany.33 In this report theworld supply ofradium (in the form ofradiumbromide)
was assessed at 9 grams, ofwhich one-third wasunderAustrian authority. Two grams
were held in the Institute ofPhysics atVienna, while three-quarters ofa gram were on
loan to England. In Paris, Marie Curiehad one to oneand ahalfgrams, whilethe rest
was distributed over numerous institutes all over the world. The worrisome situation
for Germany is clear from the following summary: in Berlin the Akademie der
Wissenschaften (Academy ofSciences) held 27 mg semi-pure and 8 mg pure radium
bromide, while even less was available at the Charite and at the Technical University.
Von Trott zu Solz argued that one quarter ofa gram was urgently needed to keep up
with ongoing research. As the price of 1 mgradium bromide had risen from 12 Marks
to 150 Marks over the previous decade, the Emperor was asked to make available
37,500 Marks for the purchase ofthat quarter ofa gram, which was to be supplied by
the Chininfabrik Buchler & Co. at Braunschweig.
In response to the excitement caused by Kronig's presentation at the Congress of
Gynaecologists, August von Wassermann, who had devised the serological test for
syphilis which was named after him, was asked in the same year to evaluate cancer
treatment byradium andmesothorium.34Wassermann statedthattheresults obtained
by treating tumours with rays emitted by radium or mesothorium were most
promising and that clinicians were already becoming bold enough to speak of
"curing" cancer. However, the action of these rays had to be a direct one, meaning
that radioactive rays were ineffective where the tumour had already metastasized
and the tumour cells had spread through the body. Wassermann reported that the
gynaecologist Kronig made use of 400 to 500 mg of radioactive substance. He also
stated that the production ofmesothorium, the alternative for radium, was difficult
"' Letter from Paul Ehrlich; GStA I. HA Rep 33Letter from von Trott zu Solz, 11 Sept.
89 nr. 24528, p. 57 e.v. (no date). 1909; GStA I. HA Rep 89 nr. 24528, 54-56a.
32On the influence of chemists on the German 3' Letter from August von Wassermann, 16
Empire, see Jeffrey A Johnson, The Kaiser's June 1913; GStA I. HA Rep 89 nr. 24528, 104-9.
chemists: science and modernization in Imperial
Germany, Chapel Hill, University ofNorth
Carolina Press, 1990.
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and costly. The German Glihlicht Gesellschaft (Gas Mantle Company) had an
annual production of 2 g, and in 1913 each mg cost 200 to 300 Marks.35
Because of the price and scarcity of mesothorium, it was suggested in the press
that its production should perhaps be brought under public ownership. Von Trott
zu Solz advised the Emperor regarding the medical use of radioactive substances.36
He stated that medical treatment required at least a sample of 200 mg ofradium or
mesothorium (which could of course be used repeatedly) and that "the areas of
gynaecological disorders, surgery, skin and venereal diseases, internal medicine and
ear, nose and throat diseases" were proper fields ofuse. In cases where radiotherapy
did not cure, it was at least effective in killing pain, which was a valuable application
of these substances in itself. Therefore, the Minister of Science had acquired 1250
mg of radium and 250 mg of mesothorium for a total sum of 500,000 Marks. As
regards the nationalization of mesothorium production, von Trott zu Solz had
himself been advised by Germany's most renowned chemists and physicists, Otto
Hahn, Emil Fischer and Walther Nernst. The latter arrived at the following con-
clusions.
Mesothorium was produced frommonazite, which wasmined only in Brazil. From
1 metric ton ofmonazite, 2 to 2.5 mg mesothorium was produced. If mesothorium
was to be produced by the state, it would cost 320 to 400 Marks per mg, which was
about twice the price current at that moment. Furthermore, numerous production
installations would have to be bought, as well as compensation paid for the various
patents to the companies affected.37 Worldwide, about 7 grams ofmesothorium were
producedeachyear, ofwhichabout 5 gramswereextractedinGermany. Furthermore,
there was the real possibility that Brazil would work up mesothorium byitself,just as
Austriahaddone withtheproduction ofradium. In a report to the Ministerialdirektor
(secretary general), Naumann, Walther Nernst therefore urged that the usefulness
ofmesothorium should not be made public: "Let us hope the German press will not
make too much of the importance of mesothorium, as this might lead to increases
in the price that German industry has to pay for the raw material, i.e., monazite."38
But there were other arguments for not bringing the production ofmesothorium
underpublicownership. First, therewastherealpossibilitythatradioactivesubstances
would shortly be produced artificially. Furthermore, in a report to von Trott zu
Solz, the organic chemist Emil Fischer argued that in the near future tumours could
perhaps be destroyed by making use ofX-rays or chemotherapy, which implied that
radium and mesothorium would no longer be indispensible. Fischer, a 1902 Nobel
laureate, concluded in 1913: "I am therefore of the opinion that X-rays should be
utilized, and that small, suitable machines should be constructed for this purpose."39
3 Although clinics could actually purchase 36Letter from von Trott zu Solz, 22 Sept.
mesothorium, individual doctors were only 1913; GStA I. HA Rep 89 nr. 24528, 110-15.
allowed to hire it, in order to prevent 37 Ibid.
monopolization and speculation. See 38Letter from Walther Nernst, 31 Aug. 1913;
Verhandlungen der Deutschen Gesellschaftfar GStA I. HA Rep 89 nr. 24528, 124-7, p. 127.
Gyndkologie-Funfzehnte Versammlung Abgehalten 39Letter from Emil Fischer, 6 Sept. 1913;
zu Halle a. S. am 14.-17. Mai 1913, Leipzig, GStA I. HA Rep 89 nr. 24528, 121-3, p. 123.
Johann Ambrosius Barth, 1914, p. 394.
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A Ray of Hope:
The Institut fur Krebsforschung, 1903-1928
The successes of medical science, and bacteriology in particular, during the last
decades of the nineteenth century stimulated a renewed attack on cancer. Despite
the progress of pathology, the cause of cancer still was a mystery. In 1900 the
decision was taken in Germany to organize a census or Sammelforschung regarding
cancer, in order to investigate whether proof could be obtained of the infectious
nature ofthe disease. Chaired by Ernst von Leyden, head ofthe First Medical Clinic
of the Charite, the Komitee fur Krebsforschung (Cancer Research Committee) was
founded. At its inauguration, von Leyden declared himself a proponent of the
parasitical hypothesis in the question of cancer etiology: "The theory which is now
gaining prominence, and to which I myself fully subscribe, is that of the parasitical
nature of cancerous diseases. It is the only theory which is in sufficient agreement
with the observations and with current biological views."'
In order to confirm or refute this hypothesis, von Leyden established the Institut
fur Krebsforschung (Institute for Cancer Research) in 1903, with Ferdinand
Blumenthal as physician in charge. The Institute was small, consisting oftwo wards
for ten patients each (one for men, one for women) and one laboratory.4'
In 1911, von Wassermann reported on a presumed medical breakthrough in that
he had found that transplantation tumours (i.e. tumours cultured by transplantation
and thus not developed spontaneously) in mice could be made to regress when the
mouse was treated with a selenium compound. Although this was only an animal
cancer model, it was received as a possible breakthrough for humancancer.42 Because
of this apparent progress in cancer chemotherapy, and after the sudden death of
von Leyden in 1910 in a car accident, the Institute was placed under the directorship
of the chemist Emil Fischer, with Georg Klemperer as chief physician. Fischer
and Klemperer pursued the application of chemotherapy, especially of selenium
compounds, in cancer patients, but in 1914 they had to conclude that this type
of compound had no beneficial effect on human cancer. Subsequently, Johannes
Orth-Rudolf Virchow's successor as head of the famous Pathological Institute of
the Charite-was placed in charge of the Institut fur Krebsforschung, although the
de facto day-to-day management was in the hands of Ferdinand Blumenthal.
Blumenthal initiated a variety of experimental research projects, many of them
experimental models which were unconventional for the clinician: transplantation
tumours, chemical carcinogenesis by Teerpinseln (tar painting) of mice and rats,
4 Ernst von Leyden, Kirchner, et al., completed his Habilitation in 1899. Besides
Verhandlungen des Comit&sfdr Krebsforschung - working at the IfK, Blumenthal was head of
Heft I. 1900-1902, Sonderabdruck aus der internal medicine at the Israeli Hospital from
'Deutschen Medizinischen Wochenschrift', 1902 to 1923.
Jahrgang 1900-1902, Berlin, G Bernstein, 1902, 42 See August von Wassermann, Franz
pp. 3-4. Keysser, and Michael Wassermann, 'Beitrage zum
4 Ernst von Leyden, and Ferdinand Problem: Geschwuilste von der Blutbahn aus
Blumenthal, 'Die Abteilung ftlr Krebsforschung therapeutisch zu beeinflussen', Dtsch. med.
an der I. medizinischen Universitatsklinik', Wochenschr., 1911, 37: 2389-91, and anon.,
Charite-Annalen, 1904, 28: 36 44. Ferdinand 'Kleine Mitteilungen', ibid., 1911, 37: 2391-2.
Blumenthal defended his MD thesis in 1895 and
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Rous sarcoma in chickens, and crown galls of plants. To many clinicians, the
relevance ofsuch experimental models for the problem of human cancer was by no
means evident. One argument for this scepticism was the difference between the
results of chemotherapy in animals and humans.43 Orth had also succeeded von
Leyden as chairman ofthe Deutsche Zentralkomitee fur Krebsforschung (the former
Komitee fur Krebsforschung) and after the withdrawal of the first secretary of the
committee in 1919, Blumenthal took over this function."
Even under Georg Klemperer, the IfK had been in need of an outpatient clinic in
order to contact patients as soon as possible, and to intervene in the disease process
in its earliest stages. This would allow the latest diagnostic methods and therapies
to be tried and evaluated. In 1911, Klemperer therefore asked Naumann for per-
mission to open an outpatient clinic, arguing that there was a special need for
patients who had not yet been clearly diagnosed with cancer. Sometimes it took
several weeks before the decision was made to operate, and meanwhile the ambulant
patient could be diagnosed in more detail. Subsequently, surgery could be performed
at the surgical clinic. Klemperer emphasized that until then the IfK had mostly
received patients who were in a desperate condition. The reason was that the intake
of patients was indirect, through referral from the other Charite institutes. This
resulted in a situation "in which our patients come from clinics which allow them
to come here only after they have lost any practical medical or scientific interest in
them and when only the human aspect of euthanasia can be considered".45 Ernst
Piutter, the Verwaltungsdirektor (administrative director) of the Charite, underlined
the IfK's need for patients in the "various stages of the disease" and therefore of a
Poliklinik fuir Krebskranke und Krebsverdachtige (Outpatient Clinic for Cancer
Patients and Cancer Suspects).' The IfK's wish was to be granted in 1915.
Klemperer'sletter,quotedabove,revealsatensionbetweentheInstitutfurKrebsfor-
schung and the other specialist fields which were involved in cancer patient care, such
as surgery, internal medicine and gynaecology. Klemperer hastened to state that the
IfKwouldneveradmitpatientstoitsbedswhowereoperable; theseweretobereferred
for surgery immediately. But there were also many tumours which were inoperable,
such as those in thepleura, the lungs, the liver, spleen, thymus, stomach and, to some
extent, in the intestine, as well as patients who had already been operated upon but
who had suffered relapses (often cases ofcancer of the breast or cervix). Klemperer
was aware that an outpatientclinic would provoke opposition from the other Charite
clinics, but gave the assurance that: "There wouldbe no competition with the surgeons
43This argument is elaborated in Ton van Bekampfung der Krebskrankheit (1900-1933)',
Helvoort, 'A dispute over scientific credibility: the PhD thesis, Ernst-Moritz-Arndt-Universitat
struggle for an independent Institute for Cancer Greifswald, 1989.
Research in pre-World War II Berlin', Stud Hist. 45Georg Klemperer to Naumann, 22 May
Philos. Biol. Biomed Sci., 2000, 31: 315-54. 1911; HUA Char.-Dir. nr. 949, 303-5, pp. 303-4.
4 Matthias Kaiser, 'Zur Geschichte des 4 Ernst Ntter, 22 Dec. 1914; HUA Char.-Dir.
Deutschen Zentralkomitees zur Erforschung und nr. 950, 117-19, p. 117a.
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whatsoever. Our department would select internal, inoperable cases or inoperable re-
lapses ofexternal cancers."47 (Emphasis as in the original.)
After Blumenthal had been put in charge of the IfK, the relationship with the
surgeons was one of careful manoeuvring. In a letter to the Ministerfur Geistliche
und Unterrichts-Angelegenheiten (Minister for Educational and Spiritual Affairs)
Blumenthalwrotethatausefulcooperation hadbeenestablished betweenhisInstitute
and the Surgical Clinic. Those patients who were operable were referred, while the
surgical department "sends us the tumours removed at operation, and we use them
to prepare a vaccine with which we immunize the patients in order to induce their
bodies to form antibodies against tumour relapses".48 Although Blumenthal stated
that the relationship with surgery was more or less harmonious, Naumann informed
Blumenthal that the Charite was mounting fierce resistance against the Institute.
Briefly, the argument was: "The scientific research was done in other institutes, while
the cancerpatients could be treated at the appropriate clinics." However, Blumenthal
also experienced firm support from, for example, Johannes Orth ofthe Pathological
Institute, who had been Blumenthal's supervisor when he started his career, as well
as from Ernst Puitter and from Naumann himself.49
For its research into the etiology and treatment of cancer, the IfK thus needed
patients in the early stages of the disease. On the other hand, even the desperate
cases ofinoperable cancerpatients had to be offered somehope, otherwise theywould
seek help from quacks, homoeopaths, and so-called "biochemists".50 Blumenthal held
the opinion that one had to fight cancer by, in current terminology, a multi-modality
regime in which surgery, chemotherapy, radiotherapy and immunotherapy eachmade
its own contribution. For Blumenthal, cancer treatment had to be comprehensive,
with local control oftumours being implemented by surgery and radiation. This was
supplemented by the systemic and constitutional treatment of the disease, in which
chemotherapy and immunotherapy were additional treatment modalities, to aid the
patient's convalescence. Except for smaller surgical manipulations, no substantial
surgery took place at the IfK.5' Under Blumenthal's directorship, radiotherapy
becamethefoundationofthe Institute onthebasis ofwhicheven themostdesperately
ill cancer patient could be offered a ray ofhope for recovery and at least some form
47Klemperer to Naumann, 22 May 1911;
HUA Char.-Dir. nr. 949, 303-5, p. 303a, p. 304,
respectively.
48 Blumenthal to the Minister fur Geistliche
und Unterrichts-Angelegenheiten, 23 June 1915;
HUA Char.-Dir. nr. 950, 150-8, p. 155.
Immunotherapy, however, has now regained great
interest, after having been out of favour for quite
some time. See, for instance, Hall, op. cit., note 2
above. See also Martin Gore and Pamela Riches,
'The history ofimmunotherapy', in M Gore and
P Riches (eds), Immunotherapy in cancer,
Chichester, John Wiley, 1996, pp. 1-9.
4 Ferdinand Blumenthal, Rhoda Erdmann,
Ludwig Halberstadter, and Hans Hirschfeld, Zum
25jdhrigen Bestehen des Universitdtsinstituts far
Krebsforschung an der Charit, am 8. Juni 1928,
Berlin, Julius Springer, 1928, pp. 12, 5,
respectively.
5Ibid., pp. 7-9.
51 Ferdinand Blumenthal, '25 Jahre
Krebsbehandlung', Med Klinik, 1925, 21: 533-6.
Remarkably, arsenic compounds were used with
the intention of improving the patient's condition.
Those who conceived of cancer as a
constitutional or systemic disease believed that
surgery and radiotherapy were not aimed at the
real cause ofcancer; after all, cancer's etiological
agent had not been found. Therefore, these
interventions were not cancer cures, they only
prolonged life. See Hansemann, op. cit., note 18
above; and Otto StrauB, 'Das
Krebsheilungsproblem', Zeitschriftfur
Krebsforschung', 1923, 19: 185-206.
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Table I
Radiotherapeutic treatment at the Berlin Institut
Krebsforschung from 1922 to 1927
fur
I. Malignant tumours:
skin
larynx
lungs and bronchi
oesophagus
rectum
stomach
bones and joints
mouth and pharynx
cervix
breasts
other locations
II. Other diseases:
Total:
159
82
34
152
131
68
53
183
258
708
686
1,353
3,867
of relief. This, however, was to bring Blumenthal and the IfK into conflict with
those who used the scalpel as the main weapon against cancer.
That the IfK applied radiotherapy to a substantial number of patients with
malignant and benign tumours is apparent from the numbers listed in Table 1,
coveringtreatmentduringthesixyearsfrom 1922until 1927.52 InspiteofBlumenthal's
reassurance that there would be no competition between his Institute and those
clinics where cancer patients were traditionally taken care of, the above data show
that such a tension was almost inevitable. Furthermore, Blumenthal had a critical
attitude towards operating on a cancer patient. Relapses after operations were
commonly explained on the basis that surgery had apparently been performed at
too late a stage or that not all the cancer cells had been removed. Blumenthal,
however, held the opinion that the body was able to destroy metastasized cancer
cells through its immune system. But a major operation would exhaust the body
and shift the balance of the struggle towards the cancer cell:53
It often seemed as if the operation actually provoked a generalization of the disease. This
could be explained by assuming that even before the operation, biologically latent cancer cells
52Ludwig Halberstadter, 'Die
Bestrahlungsabteilung des Instituts fOr
Krebsforschung', in Blumenthal, et al., op. cit.,
note 49 above, pp. 28-36.
3'Denkschrift uber die wissenschaftliche
Tatigkeit des Universitatsinstituts fur
Krebsforschung an der Charite in den Jahren
1917-1920', 1 April 1920; HUA Char.-Dir. nr.
951, 56-65, p. 59a. Recent studies indicate that
there may indeed be a mechanism that triggers
latent tumour cells in the body after surgery.
Presumably, this is not so much related to an
impairment of the body, as to the fact that a
tumour secretes one or more substances which
suppress stroma formation elsewhere in the body.
Such processes are now being studied under the
concept of angiogenesis; see, for instance, Roy
Bicknell, Claire E Lewis, and Napoleone Ferrara
(eds), Tumour angiogenesis, Oxford University
Press, 1997.
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are distributed throughout the body, which are then stimulated to grow as the organism is
weakened by the operation.
Obviously, the numbers in Table 1 leave unanswered the question ofthe therapeutic
effect ofradiotherapy at the IfK, and how this compared with the efficacy ofsurgery.
As Ilana Lowy has shown, stringent clinical trials are arelatively recentphenomenon.
Unsurprisingly, most pre-Second World War studies did not report comparative
results.54
During the first decades of the twentieth century, surgery had a poor reputation
and a diagnosis of cancer was perceived as a death sentence. One critic of surgery
stated in the early 1930s: "Instead of telling us tales of the Arabian Nights, the
surgeons and gynaecologists should tell us frankly how many patients treated by
them were still alive 5, 10, 15 years afterwards."55 In 1933 the Wiirzburg surgeon
Fritz Konig carried out a survey in which 60 hospitals were approached and 33
responded. Three thousand patients were reported to be free of tumours after five
years, most of whom had been operated upon, while only a few had received no
treatment apart from radiotherapy. Konig concluded that "even the most obdurate
pessimist cannot doubt the effectiveness of surgery in cancer control".56
The Festschrift of the Institut fur Krebsforschung on its twenty-fifth anniversary
did not contain figures about the efficacy of radiotherapeutic treatment. There are
obvious reasons for this. First, radiotherapy was still in its developmental stage, so
the technique was changing rapidly over time. Second, in 1939 the radiotherapist
Otto Juingling from Kiel had analysed why comparative studies were so difficult to
perform: the therapists had to work along strict rules of statistics; furthermore, the
patientsundergoingdifferenttreatmentshadtobeinasimilarclinicalstage.According
to Julngling, only centralizedcancer institutes could satisfy such requirements: "Such
exemplary reports are available from large centres in Stockholm, Paris and Zurich
and from American authors".57
The question about the best treatment modality for cancer-surgery or radio-
therapy?-led to tensions between those who operated rays and those who used the
scalpel. This was the case in Germany as well as in other countries. However, the
fact that X-ray and radium techniques were developed into expensive instruments,
and that X-rays and radioactive substances were dangerous, stimulated the cent-
ralization of radiotherapy in large treatment centres, as well as the establishment of
organizations for the administration of the radium supplies, the training of staff to
handle X-rays and radioactive substances and the introduction of new legislation.
The virtual non-existence of cancer charities and the strong opposition to the
centralization by medical specialists meant that radiotherapy took a different course
in Germany to that in many other countries.
5' Ilana L6wy, 'The culture of clinical 56Ibid., p. 264.
experimentation in oncology', in idem, op. cit., 57Otto Jungling, Allgemeine Strahlentherapie:
note 2 above, pp. 36-83. Licht, Rontgenstrahlen, Radium, Stuttgart,
55Cited in Fritz K6nig, 'Die Chirurgie und Ferdinand Enke, 1938, pp. 236-9, quotation on
Krebsbekampfung', Archivfar klinische Chirurgie, p. 236.
1939, 1%: 260-7, p. 263.
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Philanthropy and Radium Therapy outside Germany
This section presents a brief overview of the development of radium therapy in
France, Sweden, the United States and Great Britain.58 In these countries, the high
cost of radium played a crucial role in its control and in the centralization of
radiotherapy.
In France, the Laboratoire Biologique duRadium(Biological Radium Laboratory)
was established in 1906 under the auspices of Armet de Lisle, director of a radium
factory, andin 1912theRadiumInstitutecameintobeing.OneyearlatertheUniversity
of Paris and the Pasteur Institute established ajoint project on research into radio-
therapy,givingthreemainreasons: (i)tolinkanimalexperimentswithclinicalresearch;
(ii) to amelioratethecollaboration between surgeonsandradiologists; (iii)becausethe
new equipment was so costly that only co-operation couldjustify the large expense.59
The research into radium and its application was strongly stimulated when in 1921
Marie Curie received from the American Women's Movement a gift of 1 gram of
radium. Furthermore, she waslent several grams ofradiumbythe parent company of
the Belgian Mines du Haut-Katanga (Upper Congo Mines). At Villejuif, a southern
suburbofParis,GustaveRoussyestablishedanewcancercentrein 1920,whichinitially
wassmallbutsoonsawmajorexpansion. Inthe 1920s,adepartmentoftelecurietherapy
(Fernbestrahlung, Tieftherapie, deep therapy) had been established here, headed by
Simone Laborde, inwhich usewasmade ofa "radiumbomb" containing 10 grams. In
the late 1920s, only six of these instruments, containing such a massive amount of
radium, were operational and two ofthem were located in Paris, one in Villejuifand
the other at the Radium Institute.60
In Sweden, Tor Stenbeck and Tage Sjogren were the founding fathers of radio-
therapy. They startedwith self-madeX-raymachines, which wereusedfordiagnostics
as well as for therapy. One of Stenbeck's pupils, Gosta Forssell, was to become the
Nestor ofSwedish radiotherapy. He worked at the Serafimer Hospital, the university
hospital in Stockholm, whose X-ray department moved to a separate house nearby
in 1910. This was named Radiohemmet (Radio Home). Subsequently, both the city
of Stockholm and the state of Sweden became involved in radiotherapy. In 1916 a
new building was opened, with 34 beds for patients.
For the history of radiotherapy in Sweden, 1928 was a crucial year. On the
occasion of the seventieth birthday of King Gustav V, the Swedish people offered
him apresent of6million crowns. This giftwaspassed on to the Swedish organization
58 also Jacques Bandaline, La lutte Metailie, 1992, and Benedicte Vincent, 'Genesis of
internationale contre le cancer Premiere partie: la the Pavillion Pasteur of the Institut du Radium
conception canc&rologique ai travers les siecles et la ofParis', Hist. Tech., 1997, 13: 293-305.
lutte contre le cancer en France-Deuxieme partie: 6 In 1934 the cancer centre at Villejuif became
organisation de la lutte contre le cancer dans les the French National Cancer Institute, known as
diverspays, Paris, Maloine, 1933; and Cantor, op. the Institut Gustave Roussy from 1948 onwards.
cit., note 1 above, pp. 547-52. For a history of radiotherapy in France, see
59Patrice Pinell, 'Naissance et developpement Maurice Tubiana, Jean Dutreix, and Bernard
de la radiotherapie en France', Medecine Pierquin, 'One century ofradiotherapy in France,
Sciences, 1995, 11: 1596-9; see also Patrice Pinell, 1896-1996', Int. J. Radiat. Oncol., Biol., Phys.,
Naissance d'unfleau. Histoire de la lutte contre le 1996, 35: 227-42.
cancer en France (1890-1940), Paris, Editions
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for cancer control and was used, among other things, to establish centralized cancer
treatment institutions.6' Gosta Forssell became an important spokesman for those
who defended the centralization of cancer control as the most effective way of
organizing it.
In the United States, the availability ofradium had improved after the mid-1910s,
when the US Bureau of Mines and the American Institute of Radium-founded by
HowardKelley, agynaecologist fromBaltimore, andtheengineerJamesDouglas-set
up a radium production plant in Denver. Until 1922, when uranium ores were
discovered in the Belgian Congo, the main part of all the radium in the world was
tobefoundintheUnitedStates. JamesDouglasdonatedhisshareofthecompany-in
the form of several grams of radium-to the Memorial Hospital for the Treatment
of Cancer and Allied Diseases in New York.62 Headed by the surgeon Henry H
Janeway and the physicist Gioacchino Failla, the Memorial became a centre of
expertise for radium therapy.63 Besides the Memorial at New York, the Collis P
Huntington Memorial Cancer Hospital in Boston was also an important centre.
In England, N S Finzi, the author of the first 1913 textbook on radium therapy,
brought together 600 mg ofradium for the treatment ofa millionaire suffering from
cancer of the bladder in 1911. During the First World War, radium was used in
aeroplanes, for dials and indicators, and at the close ofthe war the Royal Air Force
had a surplus of 5 grams, which was donated to the Medical Research Council. The
MRC loaned the entire 5 grams to the Middlesex Hospital in London, predominantly
for the treatment of cancer but also for experimental work. However, within two
years the radium was split and divided among several clinical institutions. In 1929
the British National Radium Commission was formed to control the distribution of
radium among other things to a dozen regional cancer treatment centres.54
From this brief outline of developments in four countries, we can conclude that
in the second half of the 1920s important cancer hospitals and cancer research
institutions were set up in each ofthem. The role ofphilanthropy in the development
of cancer control in all these countries is most remarkable. The precious nature of
radiumand its scarcity were important factors inthecentralization ofradiumtherapy
at various levels. In centralized cancer institutes, surgeons and radiotherapists were
more or less forced to co-operate. A chronicler of radiotherapy in Sweden stated
that because of the existence of consultative structures in that country "there has
61 Later, central cancerclinicswere established 61 For a history of radiotherapy in England,
at Stockholm (1937), Lund (1941) and Gothenburg see J Michael Henk, 'A brief history of British
(1943). These were named King Gustav VJubilee radiotherapy', Int. J. Radiat. Oncol., Biol., Phys.,
Clinics. For ahistory ofradiotherapy in Sweden, 1996, 36: 213-18. For a discussion of the control
see Elis Berven, 'The development and and regulation of radium for the purpose of
organization oftherapeutic radiology in Sweden', experimental and clinical research before the
Radiology, 1962,79: 829-41. Second World War, see David Cantor, 'The
62For a history of radiotherapy in the United MRC's support for experimental radiology during
States, see Juan A Del Regato, 'The unfolding of the inter-war years', in J Austoker, and L Bryder
American radiotherapy', Int. J. Radiat. Oncol., (eds), Historicalperspectives on the role ofthe
Biol., Phys., 1996, 35: 5-14. MRC, Oxford University Press, 1989, pp.
63See, for instance, Gioacchino Failla, 181-204; see also Joan Austoker, A history ofthe
'Radium technique at the Memorial Hospital, Imperial Cancer Research Fund 1902-1986,
New York', Radium, Nov. 1920, 16: 17-32. Oxford University Press, 1988.
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never been any kind ofa fight for the patient material between the different medical
branches".65 Although such statements of friendly co-operation have to be viewed
with a certain scepticism, it will become clear below that in Germany radiotherapy
matured in a wholly different atmosphere.
Blumenthal and the Centralization of German
Radiotherapy, 1928-1933
In 1928, the Institut fiur Krebsforschung celebrated its twenty-fifth anniversary. In
thatyear,FerdinandBlumenthalwasappointedextraordinaryprofessorandfromthen
on the IfK was financed by the state Otatmassig). Both the Institute and Blumenthal
himselfwere internationally recognized as prominent players in cancer research and
treatment, asdemonstrated bythe factthathewas one oftwo Germanparticipants at
theCancerControlconferenceinSeptember 1926.66 SeveralemployeesoftheInstitute,
such as the radiotherapist Ludwig Halberstaedter and the haematologist Hans
Hirschfeld, were among the most respected experts in their specialisms.67
The developments abroad outlined in the previous section highlighted the sore
point ofradium shortage in Germany. In the press this became known as the "radium
problem". In order to delineate a policy regarding the future of radiotherapy
in Germany, a commission of the Deutsche Zentralkomite zur Erforschung und
Bekampfung der Krebskrankheit (DZK, German Central Committee on Cancer
Research and Control) visited some of the radiotherapy facilities in France and
Sweden. The members of the committee were Ludwig Halberstaedter of the IfK,
two of the founders of the journal Strahlentherapie-Richard Werner (Heidelberg)
and Hans Meyer (then in Bremen)-and Walter Friedrich of the Institut fur Strah-
lenforschung (Institute for Radiation Research) of Berlin University.68 The con-
clusions ofthis committee, set out in a report 'Bericht der Radiumkommission uiber
ihre Reise nach Paris und Stockholm' (Report ofthe Radium Committee on its Visit
to Paris and Stockholm) were for the greater part adopted by the DZK, resulting
in the following targets being set for the control of cancer in Germany:69
65Berven, op. cit., note 61 above, p. 837.
6 American Society for the Control of Cancer,
op. cit., note 4 above.
67 On Halberstaedter, see anon.,
'Halberstaedter, Ludwig', in H A Strauss and W
Roder (eds), Biographisches Handbuch der
deutschsprachigen Emigration nach 1933-Band II,
Munich, K G Saur, 1980, p. 452; on Hirschfeld,
see Peter Voswinckel, 'Von der ersten
hamatologischen Fachgesellschaft zum Exodus
der Hamatologie aus Berlin', in W Fischer, K
Hierholzer, M Hubenstorf, P Th Walther, and R
Winau (eds), Exodus von Wissenschaften aus
Berlin: Fragestellungen Ergebnisse Desiderate-
Entwicklungen vor und nach 1933, Berlin, Walter
de Gruyter, 1994, pp. 552-67.
68 In 1914, the medical physicist Walter
Friedrich went to Freiburg im Breisgau to co-
operate with gynaecologist Bernhard Kronig (see
section 2 of this essay). In 1922, Friedrich was
appointed director of the newly established
Institut fur Strahlenforschung of the Medical
Faculty of Berlin University, an institute which
was finished only in 1928. In Berlin, Friedrich
would no longer co-operate with clinicians as he
had done at Freiburg. (In 1950, he was appointed
rector of the East Berlin Humboldt University.)
See Walter Friedrich, 'Das neue Institut fur
Strahlenforschung der Universitat Berlin',
Strahlentherapie, 1929, 34: 223-46; K Eckoldt,
'Walter Friedrich-Wissenschaftler, Humanist
und Friedenskampfer', Charite-Annalen N. F,
1984, 3: 289-95.
69Report filed on 6 July 1929; GStA I. HA
Rep 76, nr. 3852, 279-302. See also Kaiser, op.
cit., note 44 above, pp. 21-4.
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-urging cancer patients to visit a doctor as soon as possible;
-further development and intensification ofexisting cancer research institutes;
-the creation of centralized institutes, possibly linked to the cancer institutes at Berlin and
Heidelberg so that telecurietherapy could be effected (in all about 6 grams of radium were
thought to be needed);
-establishment of smaller offices for cancer consultation and treatment with other forms of
radiotherapy;
-centralization of radium and mesothorium supplies, and organization of a rational dis-
tribution of the capacity in radiotherapy;
-regulating the handling and use ofradioactive substances such as radium and mesothorium,
so that only trained personnel and therapists would be allowed to work with them.70
Similar themes were discussed on 31 May 1930 at a hearing organized by the
Landesgesundheitsrat (County Public Health Board) on the future ofcancer control.
The debate was opened by contributions from Ernst Putter (administrative director
of the Charite) and Ferdinand Blumenthal.7' The latter pleaded for a centralized
organization of radiotherapy to make sure that education, training and quality
control could be dealt with effectively. Blumenthal concluded that radiotherapy had
been introduced too rapidly, so that there was insufficient supervision of a risky, not
to say potentially dangerous, technique. He argued that everyone had access to
capable surgeons but that things were different for radiotherapy in general, and
radium therapy in particular: "It would be a gross underestimation of X-ray and
radium treatment to believe that it would suffice to put enough radium into the
hands of an otherwise competent physician to achieve satisfactory radiotherapy."72
Subsequently, the purchase of and control over radium and mesothorium were
discussed and Blumenthal argued that this necessitated central institutions. Fernbe-
strahlungen or deep therapy (as opposed to direct application, also known as
"brachytherapy") was not required so frequently that facilities had to be available
everywhere. Blumenthal's conclusion was that the developments abroad should be
taken as an example: "We should therefore proceed along the same lines as Sweden
and France, i.e., concentrating the equipment for high-dosage telecurietherapy in a
few places, while most cases are treated with smaller doses in those same or other
places."73
Moreover, Blumenthal argued for the establishment of a Prufungskommission
(assessment committee), which would monitor the expertise of those working in
701In 1931, Walter Friedrich stated that for und Verteilung radioaktiver Substanzen fiUr die
Germany the most relevant solution for the Krebsbekampfung in Deutschland und im
"radium problem" would be to follow the Ausland', in F GrQineisen (ed.), Krebsbekimpfung:
example of Great Britain, where a "middle course Jahrbuch des Reichsausschusses far
had been adopted between centralization and Krebsbekampfung 1930, Leipzig, Johann
decentralization". In London, two dozen Ambrosius Barth, 1931, pp. 86-90, p. 87.
hospitals had been provided with smaller or 71 Ernst PUtter, Ferdinand Blumenthal, et al.,
medium amounts of radium, while four "Central 'Organisation der Krebsfarsorge [Bericht uber die
Cancer Institutions" had been supplied with 1-2 Sitzung eines zusammengesetzten Ausschusses des
grams of radium; one of these had a radium Landesgesundheitsrats am 31. Mai 1930]',
bomb containing 4 grams of radium for Ver6ffentlichungen aus dem Gebiete der
telecurietherapy. Over the whole of Britain, a Medizinalverwaltung, 1930, 32: 635-94.
dozen treatment centres held medium amounts of 72Ibid., p. 651.
radium. See Walter Friedrich, 'Die Beschaffung 73Ibid., p. 652.
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radiotherapy. This would result in better protection of patients as well as doctors
and therapists against the harmful effects ofradioactive rays. All this had to be laid
down in legislation.
The work of the radium committee of the DZK testifies to the importance
radiotherapy had gained in the treatment of cancer. Not only were the pros and
cons of introducing regulation of radiotherapy discussed but also who would have
jurisdictionoverthetechnique. WalterStoeckel,headoftheUniversitats-Frauenklinik
(University Gynaecological Clinic) ofthe Charite, warned against the consequences
ofcentralizing radiotherapy: "Founding centralized cancer institutes would provoke
further opposition from all sides, including specialists and specialized institutes. It
would arouse the not unreasonable fear that a major part of their own work might
be taken away from them."74 He was referring to the surgeons, gynaecologists,
dermatologists, oto-laryngologists and to a lesser extent orthopaedists. These spe-
cialists claimed that cancer as a disease ofa specific organ had to be treated by those
who were experts in that particular medical domain. Thus, cancer of the cervix fell
under the jurisdiction of gynaecologists. According to Stoeckel, this situation was
the result of a historical process which should not be interfered with by creating a
new specialism encompassing different fields of expertise. Stoeckel clearly opposed
the centralization of radiotherapy striven for by Blumenthal, but the latter secured
support from, for instance, the Cologne radiologist Werner Teschendorf, who openly
advocated the establishment ofspecial clinics for radiotherapy. Teschendorfclaimed
that much "cancer therapy" was being lost through injudicious use.75
In 1931 Blumenthal and Teschendorf came under severe attack from the Medical
Faculty of the University of Frankfurt am Main, an attack articulated by its dean,
A Loos.76 The immediate cause which brought the different points of view into the
open was the formation of the ReichsausschuB fur Krebsbekampfung. Its in-
auguration on 25 February 1931 was a most important step, because it marked the
beginning of government participation in cancer control. And, interestingly, the
committee's chairman Bruno Dammann and secretary Felix Gruneisen seemed to
opt for the centralization ofradiotherapy as Blumenthal had advocated.77
Loos accused Blumenthal ofattempts to withdraw the treatment ofcancerpatients
from the disciplines that claimed jurisdiction over diseased organs and to establish
centralized cancer hospitals and institutes. This, he claimed, would be harmful for
the training of doctors and specialists. Loos referred to an article written by
Frankfurt's Hans Holfelder, which defended local integration of radiotherapy with
'Walter Stoeckel, contribution to the See, for instance, Goerke, op. cit., note 5 above,
discussion in PNtter, et al., op. cit., note 71 p. 100, and Teschendorf's contribution 'Zur
above, p. 680. Krebsbekampfung', in C Adam and H Auler
7Werner Teschendorf, 'Zentralisation der (eds), Neuere Ergebnisse aufdem Gebiete der
Geschwulstbehandlung', Zeitschriftfur Krebskrankheiten: 47 Vortrage, Leipzig, S Hirzel,
Gesundheitsverwaltung und Gesundheitsfursorge, 1937, pp. 208-16.
1931, 2 (2): 33-42, p. 36. 77See, for instance, Felix Gruneisen, 'Ein Jahr
76A Loos, 'UYber die zweckmassigste ReichsausschuB ftir Krebsbekampfung-1. April
Organisation der Krebsbekampfung', Dtsch. med 1930-31. Marz 1931', in Gruneisen (ed.), op. cit.,
Wochenschr., 1931, 57: 1487-9. Apparently, note 70 above, pp. 10-21.
Werner Teschendorf was spared further criticism.
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the surgical specialisms.78 Holfelder's institute was, on the one hand, a centralized
establishment with large spaces for the megavolt X-ray devices, while on the other
it was integrated with the university's surgical clinic headed by Victor Schmieden.
Holfelder stated that the X-ray department performed no surgery ofwhatever kind,
as this was the proper domain of the Surgical Clinic.79
Criticism of Blumenthal became even sharper when Germany's most prominent
surgeons, Hans Kuittner(Breslau), Ferdinand Sauerbruch(Charite, Berlin)andVictor
Schmieden (Frankfurt am Main), openlyjoined in theconflict, claiming that surgeons
were deliberately being excluded from the ReichsausschuB.80 If Blumenthal was
critical about the legitimacy of cancer surgery in many cases, surgeons were most
critical about the results claimed by the radiotherapists. They referred to patients
who "would develop into hopeless cases as a result of useless radiotherapy and so
be lost to cure". In their view, the radiotherapist was only to be called in after the
surgeon had given permission: "Generally speaking, the radiotherapist should be
called in only after the possibilities for surgical treatment have been exhausted or
have been rejected on good grounds."8'
In July 1932, the medical faculty ofBerlin University decided to cut the budget of
Blumenthal's Institut fur Krebsforschung by 20,000 Marks, of which one-fifth
affected Rhoda Erdmann's Institut fur experimentelle Zellforschung (Institute for
Experimental Cell Research). Although the latter was independent, it still was fin-
ancially tied to the IfK. Blumenthal wrote to Charite's administrative director Alfred
Kuhnert saying that a budget cut ofthis magnitude would in fact imply the end ofthe
IfKasaresearchinstitute. InBlumenthal'sview,theattackonhisInstitutewasinspired
by the competition between the IfK and the regular clinics and institutes where radio-
therapeutic devices for the treatment of cancer patients were also available. The ar-
gumentofhisadversaries, Blumenthalclaimed, wasthat"radiativetreatmentofcancer
couldjust as well be performed and developed at the surgical clinics".82 He concluded
that "theindependence ofcancerresearchandcancertreatmentinGermany[appeared
to be] under attack from two different directions-pathology and surgery".83
As mentioned above, Blumenthal devoted his experimental cancer research to a
wide range ofmodels. The conclusions drawn from these studies for the etiology of
human cancer were unacceptable to many clinicians and orthodox pathologists. To
78 Hans Holfelder, 'Gedanken zur ortlichen involved the surgeons in the committee's further
Organisation der Krebsbekiimpfung', Dtsch. med. activities. See Bruno Dammann, 'Die Ziele des
Wochenschr., 1931, 57: 659-62. Reichsausschusses fur Krebsbekampfung', ibid.,
' Hans Holfelder and Walter Korte, Das 1931, 5: 986; for his earlier position, see Bruno
Rontgeninstitut der chirurgischen Universitatsklinik Dammann, 'Wege und Ziele der Krebs-
im Stddtischen Krankenhaus Sachsenhausen in bekiimpfung', in Gruneisen (ed.), op. cit., note 70
Frankfurt a. M., Leipzig, Georg Thieme, 1929, p. above, pp. 1-9. See also Kaiser, op. cit., note 44
25. above, pp. 22-30.
80Hans Kuttner, Ferdinand Sauerbruch, and 81 Kuttner, et al., op. cit., note 80 above, pp.
Victor Schmnieden, 'Die Chirurgie des Krebses 984-5.
und die neuen organisatorischen Bestrebungen 82 Blumenthal to Alfred Kuhnert, 25 July
zur Krebsbekampfung', Med. Welt, 1931, 5: 1932; HUA Char. Dir. nr. 953, 246-53, p. 248.
981-5. In response to this, the chairman of the 83Ibid., p. 248.
ReichsausschuB, Bruno Dammann, quickly
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give an example, the surgeon Victor Schmieden, co-author of the 1931 attack on
Blumenthal, had written a few years before:
It is alien to the clinician's mode of thinking not to rely on conclusive evidence from human
materials, but time and again to be referred to mammals, thence to birds, thence to cold-
blooded animals and even to plants (sunflowers etc.)... . [WMe must warn against attaching
too much value to comparative observations from the animal or plant kingdom.'M
This comment was written in response to the publicity that the research on cancer
viruses hadreceivedinthemid-1920s.85 Andin 1937 Ferdinand Sauerbruch, co-author
ofan anti-Blumenthal article, formulated his hesitation about animal experiments as
follows: "Clinicians will be particularly apprehensive about simply transferring the
results ofanimal experiments to human pathology and about generalizing and over-
estimating the extent oftheir significance."86 Therefore, when Blumenthal wrote that
independentcancerworkwasbeingattackedbypathologyandsurgeryhehadinmind
both his research programme and the radiotherapeutic treatment ofcancerpatients.
The warm relationship between the chairman and the secretary of the Reichs-
ausschuB3 on the one hand and Ferdinand Blumenthal on the other had flagged
and the committee now established firm ties with the Deutsche Gesellschaft fur
Gynakologie (German Gynaecological Society) as well as the Deutsche Gesellschaft
fir Chirurgie (German Surgical Society). Subsequently, surgeons, gynaecologists and
other specialists succeeded in averting the centralization ofradiotherapy in Germany.
Blumenthal's Institut fur Krebsforschung received the final blow with the in-
troduction on 7 April 1933 of the Gesetz zur Wiederherstellung des Berufs-
beamtentums (Civil Law of 7 April 1933) which banned persons of Jewish descent
from entering state service.87 Since Blumenthal and almost all of his staff and
personnel were Jewish, he was forced to take early retirement; shortly afterwards he
emigrated to Belgrade where he became professor, while Ludwig Halberstaedter and
Hans Hirschfeld emigrated too.88 Hans Auler, Blumenthal's personal assistant, was
made acting director of the IfK.
84"Victor Schmieden, 'Infektion, Parasitismus
und Gewachsbildung', in G Schmorl (ed.),
Verhandlungen der Deutschen Pathologischen
Gesellschaft: zweiundzwanzigste Tagung, gehalten
in Danzig am 8.-JO. Juni 1927, Jena, Gustav
Fischer, 1927, pp. 21-36, on pp. 30, 34,
respectively.
8 Van Helvoort, op. cit., note 43 above; see
also idem, 'Viren als Krebserreger: Peyton Rous,
das "Infekti6se Prinzip" und die Krebsforschung',
in C Gradmann and T Schlich (eds), Strategien
der Kausalitat: Konzepte der Krankheits-
verursachung im 19. und20. Jahrhundert,
Pfaffenweiler, Centaurus-Verlagsgesellschaft, 1999,
pp. 185-226, and idem, 'A century of research
into the cause of cancer: is the new oncogene
paradigm revolutionary?', Hist. Philos. Life Sci.,
1999, 21: 293-330.
86Ferdinand Sauerbruch and Else Knake,
'Bericht uiber weitere Ergebnisse experimenteller
Tumorforschung', Arch. Klin. Chirur., 1937, 189:
185-90, p. 190.
87See Andreas Fijal, 'Die Rechtsgrundlagen
der Entpffichtung juidischer und politisch
miBliebiger Hochschullehrer nach 1933 sowie des
Umbaus im nationalsozialistischen Sinne', in
Fischer, et al. (eds), op. cit., note 67 above, pp.
101-15. See also Robert N Proctor, 'The
Gleichschaltung of German cancer research', in
idem, The Nazi war on cancer, Princeton
University Press, 1999, pp. 35-57.
88 See Michael Hubenstorf and Peter Th
Walther, 'Politische Bedingungen und allgemeine
Veranderungen des Berliner Wissenschafts-
betriebes 1925-1950', in Fischer, et aL (eds), op.
cit., note 67 above, pp. 5-100, pp. 34-5; see also
anon., 'Einleitung, in Strauss and Roder (eds),
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Confficting Views on the Continuation of the Institut fur Krebsforschung
After the almost complete dismantling of the IfK in April 1933, the dean of the
Medical Faculty ofthe University ofBerlin, Hermann Gocht, tried to delineate new
aims for the Institute. He was the chairman of the Deutsche Orthopadische Ge-
sellschaft (German Orthopaedic Society) andwasgreatly involvedin thedevelopment
ofradiology because ofthe crucial role X-ray diagnostics played in his profession.89
Gochtsoughtadvicefromseveral experts, includingthegynaecologistWalterStoeckel
(Charite), the surgeon Victor Schmieden (Frankfurt am Main) and the radiologists
Gosta Forssell (Stockholm) and Hans Schinz (Zurich).
In 1930, Stoeckel had warned that attempts to centralize radiotherapy would meet
with serious resistance from medical specialists. And in his advice to Gocht he was
also very outspoken against a centralized radiotherapeutic institute at the Charite:
Whenever the founding of a centralized institute for radiotherapy or the establishment of a
cancer hospital was discussed, the faculty has emphatically rejected the centralization ofeither
radiotherapy or cancer treatment. It is absolutely essential that each clinic retains the right
and has the necessary equipment to irradiate patients and treat cancers. This necessity derives
especially from the fact that radiotherapists are insufficiently trained in either diagnostics or
therapy to solve the problems that need to be solved with regard to cancer diagnostics and
cancer therapy.
Although Stoeckel admitted that radiotherapy had its place in the treatment of
cancer, he felt, nevertheless, that the main responsibility was with the clinician: "It
is only the clinician who is capable of assessing and implementing this kind of
therapy, not the radiotherapist". Stoeckel did not object to the IfK as a research
institute, as long as it did not have therapy as its main objective.'
The Frankfurt surgeon Victor Schmieden, who with Kuittner and Sauerbruch had
criticized Blumenthal openly, was asked for advice too. His view was typical of a
surgeon: (i) the cancerpatienthad to betreated bythespecialistwithcompetence over
theorganororgansaffected; (ii) surgeryhadtobethefirstlineoftreatment; (iii)cancer
treatmentshouldneverbebasedonaone-sidedradiotherapeuticapproach. Schmieden
had always been offended by the IfK's pretending to be a therapeutic institute:9'
IhavealsoalwaysresentedthepresenceintheLuisenstrasseinBerlinofaninstitutewhichopenly
advertises itselfto the public at large as atherapeutic institute for tumour diseases.... The real
tumour diseases, especially cancer, however, are so intimately linked to the various clinical
disciplines thatitwouldbeimpossibletotearthesetypesofdiseaseawayfrominternalmedicine,
surgery, gynaecology, laryngology, etc. and place their diagnosis and treatment under the
responsibility ofa special therapist who looks only at this aspect.
89Gocht's own position with respect to the (ed.), 150 Jahre Berliner Orthopadie, Berlin,
IfK did not become clear. Gocht was editor of Humboldt-Universitat, 1985, pp. 70-7.
the literature review Die Rontgen-Literatur- 'Walter Stoeckel to Hermann Gocht, no
Zugleich Anhang zu 'Gochts Handbuch der date; HUA Med. Fak. 279, Bd 1, 100.
Rontgen-Lehre', Stuttgart, Enke, 1911ff. On 91Victor Schmieden to Hermann Gocht, 6
Hermann Gocht, see Holthusen, et al. (eds), op. June 1933; HUA Med. Fak. 279, Bd 1, 27-30,
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Schmieden held the opinion that since surgery was in the vanguard of cancer
treatment, the cancer patient should seek refuge in a combination of surgical and
radiotherapeutic interventions "but not in a purely surgical, nor in a purely radio-
logical therapy".92
Stoeckel and Schmieden represented the established disciplines, but radiologists
were consulted too. Gosta Forssell, head of the Sophiahemmets Rontgeninstitut at
Stockholm, persevered in pleading for the centralization ofradiotherapy. He advised
performing radiotherapy in an independent clinic with an outpatient department,
although in "carefully organized collaboration" with the other clinics where surgery
was practised. He advised Gocht to transfer theexperimental researchto the Charite's
Pathological Institute.93
The second radiotherapist consulted was Hans R Schinz, professor of medical
radiology atZurich andchairman ofthe Fourth International CongressofRadiology,
held in Zurich in 1934. In his advice to Gocht, Schinz clearly expressed sympathetic
feelings towards National Socialism, so a pro-Blumenthal position was hardly to be
expected from him. He stated that now that the National Socialist revolution in
Germany had succeeded, the country could catch up with such countries as Sweden
with its Radiohemmet, the United States with its Memorial Hospital, Milan with
its Instituto del Cancro and Paris with its Institut du Radium. Schinz concluded
thatcancer surgeryinGermanywaswellorganized, unlike treatmentbyradiotherapy.
He held the view that centralization would be inevitable: "All leading radiotherapists
support the centralization of radiotherapy." In the Romance, Anglo-American and
Scandinavian countries, centralized cancer institutes had been founded, as it was
impossible for a radiotherapist to work efficiently "in an institute which functions
only as a nursing home for incurable cancer patients". With regard to the situation
in Germany, his judgement was most critical: "The decentralization undertaken in
most places in Germany has yielded disappointing results, and despite our great
sympathy for Germany it must be said that, except as regards gynaecological
radiotherapy, this has caused Germany, which has always marched at the forefront
ofscience, to lag behind." Schinz was familiar with the Berlin Institut fuir Krebsfor-
schung and believed that the "existing cancer institute should not only be continued
but shouldbeexpanded into aradiotherapeutic cancercentre, which shouldprimarily
be led by a radiotherapist". In such an institute there was no need for extensive
operations, as surgery and radiotherapy were independent disciplines: "A clear
separation between these two treatment modalities should and can be made."94
Schinz's views on the Berlin IfK were very similar to the objectives set out by
Blumenthal. The consultations by Gocht resulted in the same division along party
lines as had existed while Blumenthal was director of the Institute. Radiotherapists
strove for centralization oftreatment facilities, while the medical specialists defended
their jurisdiction over the use of radiotherapy.
92Ibid., pp. 29-30. 94Hans R Schinz to Hermann Gocht, 7 June
93Gosta Forssell to Hermann Gocht, 7 June 1933; HUA Med. Fak. 279, Bd 1, 40-7, pp. 41-2,
1933; HUA Med. Fak. 279, Bd 1, 31-8, p. 34. pp. 44-5, respectively.
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The Conflict over Centralization Continues
The disagreement between radiotherapists and clinicians was also apparent during
the 1934 Fourth International Congress of Radiology, chaired by Hans Schinz (in
which Blumenthal didnotparticipate). Keynote lectures weregivenbyGostaForssell
and Ferdinand Sauerbruch and the theme was the organization of radiotherapy.
Withregardtospecializationandco-operation, Forsselltookthefollowingposition:
"It is no longer a matter of whether cancer treatment should be centralized, but of
the extent to which and the principles on which this is to be implemented".95 In the
case oftreatment with radium, Forssell held that this should be performed in central
clinics for radiotherapy. Sauerbruch, who represented clinical medicine, understood
the tension between surgery and radiotherapy. He saw it as inevitable "that there
was initially a certain rivalry between the two sister disciplines, notwithstanding
their great similarity in many fundamental respects. Roentgenology tried to contest
the authority of the older surgical discipline, while the latter often out of prejudice
denied or underestimated the prospects of radiology and hence rejected it". And
with reference to Forssell's keynote address, Sauerbruch expressed his gratitude for
the "guidelines provided by his ground-breaking work, though certain details will
have to be adapted to the circumstances".96 But the crucial issue was ofcourse which
"details" would have to be adapted in order to meet the German situation.
The way Sauerbruch formulated the problem, it seemed as if the question was
over which ofthe two techniques-the use ofthe scalpel or radiotherapy-was most
beneficial to the cancer patient. But, as will have become clear from this account, it
was not so much a dispute overwhat constituted the best technique but under whose
jurisdiction radiotherapy fell.
In view ofthe contradictory recommendations Hermann Gocht received regarding
the continuation ofthe Institut fur Krebsforschung, it is not surprising that no firm
decision was reached. Temporarily, Sauerbruch was appointed curator, while Hans
Auler was in charge of the day-to-day running of the Institute. Under Sauerbruch,
experimental cancer research entered new avenues. The experimental models studied
by Blumenthal were almost all abandoned. Sauerbruch believed that the course of
a disease was determined by the body as a whole. This constitutional or patho-
physiological notion of disease had become fashionable since the 1920s and had
resulted in dietary studies and hormone research. Thus Sauerbruch and his co-
workers had developed a dietary treatment fortuberculosis.97 In cancer, disturbances
95G6sta Forssell, 'Organisation der Sitzung eines zusammengesetzten Ausschusses des
Krebsbekampfung', in H E Walther (ed.), IV Landesgesundheitsrats am 28. Februar 1930',
Internationaler Radiologenkongress Ziirich 1934, Veroffentlichungen aus dem Gebiete der
Leipzig, Kommissionsverlag Georg Thieme, 1935, Medizinalverwaltung, 1930, 32: 543-632; on
pp. 56-63, p. 61. research into constitutional aspects of disease in
96Ferdinand Sauerbruch, 'Verhaltnis der Germany see, for instance, Gerhard Koch, Die
Chirurgie zur Radiologie', in ibid., pp. 63-8, pp. Gesellschaftfur Konstitutionsforschung: Anfang
65-6. und Ende 1942-1965, Erlangen, Palm und Enke,
9 Ferdinand Sauerbruch, et al., 'Die 1985, and also Proctor, 'The Nazi diet', in idem,
Bedeutung der von Sauerbruch, Hermannsdorfer The Nazi war on cancer, op. cit., note 87 above,
und Gerson angegebenen Diat bei der pp. 120-72. For the further development of
Behandlung der Tuberkulose-Bericht uber die Gerson's dietary therapy for cancer, see S J
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of the hormone balance, for example as a consequence of advancing age, were
assumed to play a role. In his paper 'Die Bedeutung von Sexualstorungen fur die
Entstehung von Geschwuilsten' (The impact of sexual disorders on the genesis of
tumours), Sauerbruch argued that the anatomical orientation had dominated cancer
research too much, "while general pathological disorders ofthe organism as a whole
were neglected".98 The physiological approach advocated by Sauerbruch was studied
in more detail by Hans Auler, who did research on, for instance, the influence of
climate on the genesis of cancer in laboratory animals.9
As stated above, the ReichsausschuB3 fur Krebsbekampfung was initially biased
in favour ofthe centralization ofradiotherapy, a point ofview that was abandoned
under pressure from the German Societies for Gynaecology and Surgery. In spite
of this, the committee urged the National Socialist government to create three
professorships ofradiology in 1935.'° They were situated in Hamburg, Cologne and
Leipzig and it will be no surprise that Berlin was not included in the list.
In the late 1930s theconflict over radiotherapyin relation to theclinical specialisms
was as heated as it had been a decade before. At the last meeting of the Deutsche
Rontgengesellschaft (German Roentgen Society) before the Second World War, held
in May 1939 at Stuttgart, the problem was addressed again. Hans Holfelder-who in
1931 had pleaded for local radiological institutes, integrated with surgical de-
partments-now advocated the creation of centralized institutes for roentgenology,
not only for radiotherapy but for X-ray diagnosis as well. Again, the representatives
ofthe clinical specialisms objected strongly. Alfred Schittenhelm ofthe Deutsche Ge-
sellschaft fur Innere Medizin (German Society for Internal Medicine) contended that
"thevarious specializedclinics [should] beallowed tokeeptheir ownX-rayinstitutes".
Martin Kirschner, representing the Deutsche Gesellschaft fur Chirurgie, provokingly
stated thatroentgenologists wereaiming "toestablishforthemselves afreeterritoryto
workin,withoutanycompetition". AndHeinrichMartiusoftheDeutscheGesellschaft
fur Gynakologie claimed that the gynaecologist not only had to do his own X-ray
diagnostics, but should also "retain control ofhis ownradiotherapy".'°'
In 1939, the X-ray department ofSauerbruch's Surgical Institute merged with that
ofthe Institut fur Krebsforschung.'02 Meanwhile, the clinical department ofthe IfK
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was deteriorating rapidly. After a complaint from a patient in 1942, the head ofthe
Gesundheitsamt Berlin-Mitte wrote: "In any case, the nursing ward of the institute
in its present state is a disgrace and should be closed down by the police."'03 This
meant an inglorious end to an institute that had been made internationally renowned
by Ferdinand Blumenthal.
Scalpel or Rays?
The present essay has discussed how a new treatment modality for cancer-
radiotherapy-was introduced and how this technique had to struggle for a niche
ofits own. It had to compete with orthodox therapy, i.e. surgery. The development
of radiotherapy in Germany, and the history of the Institut fiur Krebsforschung of
the Berlin Charite in particular, constitutes an interesting case study because the
course taken differed from that in surrounding countries. Since centralized cancer
institutes had been established in France and Sweden, Ferdinand Blumenthal strove
for a similar role for his Institut fiur Krebsforschung; however, this metwithvigorous
resistance from the orthodox clinical specialisms.
Thatthestrugglebetweenmedical specialists andradiotherapists tryingtoestablish
an independent specialism oftheir own was so intense and protracted was related to
several specific characteristics of X-ray and radium technology, which applied not
only in Berlin and in Germany as a whole, but in other countries as well. First, the
introduction oftherapeuticX-raydevicesdeveloped fromX-raydiagnostics, the latter
technique being ofgreat importance to many medical specialisms. As the X-ray tube
and related appliances were relatively cheap, X-ray diagnostics was widely available.
When,intheearlytwentiethcentury,X-raytherapyofcancerwasinitiated,thisseemed
tobeachangeofdegreeratherthanofkind.Second,likeX-raytherapy,radiumtherapy
was a technique which was highly "democratic". Although radium and mesothorium
werecostly,inmanycasessometensorhundredsofmilligramswereenoughtoproduce
excitinglyhighratesofcure. ThesituationchangedwhenincountriessuchasEngland,
France, Sweden and the United States impressive results were obtained by using
"radium bombs", which contained grams ofradium. The radium shortage which had
been a problem in Germany from the beginning of the twentieth century was then
acutely felt. Or, as Blumenthal said at a cancer conference in 1930: "there is no other
medical discipline . . . where this lack offunds has been so noticeable-I refer to the
highprice ofradium-andwherewehave thereforebeenlaggingbehind othernations
so seriously in the research on and treatment ofcancer."'04 To sum up, radium was
both a "democratic agent" and a "centralizing agent", depending on the form of
therapy, i.e. brachytherapy orFernbestrahlung (deep therapy).
Third, another argument for centralizing radiotherapy stemmed from the inherent
hazards ofradioactive rays, which constituted a health problem for the therapist as
wellasforthepatient. Thisrequiredseveralprecautionarymeasures:(i)radiotherapists
had to be educated and trained to prevent dilettantism; (ii) legislative regulations for
03Kaiser, op. cit., note 44 above, p. 73. Dresden vom 11.-13. Juni 1930', Z.
Ferdinand Blumenthal, 'Krebskonferenz in Krebsforschung, 1930, 31: 632-6, p. 636.
58Radiotherapy in Pre-Second World War Germany
handlingradioactive substanceswereneeded; (iii)theproduction andhandlingofsuch
radioactive substances had to be restricted to specially trained andcertifiedstaff.'05 Of
course these requirements would greatly enhance the professionalization ofthe new
sub-discipline ofradiodiagnostics and radiotherapy. In the wake ofthis, professional
associations andvocational training could be taken care of.
However, there were also fundamental differences between Germany and the other
countries mentioned above. We have seen that the development ofradiotherapy was
influenced bynational political as well as economic factors. Unlike the United States,
Germany hardly possessed any uranium mines, nor did it have colonies where the
minerals could be extracted, unlike Belgium, which imported uranium ores from the
Upper Congo. A further difference between Germany and countries such as Sweden,
France and the United States was that philanthropy benefiting cancer research and
treatment played a much smaller part in the former than in the latter countries.
Although Blumenthal's Institute was supported financially by a bank and some
industries, and the Cancer Hospital (Samariterhaus) at Heidelberg depended on
private donations, these were only a fraction ofthe contributions received elsewhere,
such as James Douglas's donation of radium to the New York Memorial Hospital,
that ofthe United States to Marie Curie, and the birthday gift ofthe Swedish king
given to the Swedish organization forcancer control. This philanthropy was acrucial
factor in the "forced" centralization of radiotherapy in those countries."'6
Moreover, the German authorities long remained aloof regarding the control of
cancer, anattitudewhichalteredonlywhentheReichsausschuBfurKrebsbekampfung
was set up. Although this committee had the centralization ofradiotherapy high on
its agenda, it eventually withdrew its plans when German specialists and their
organizations opposed Blumenthal's scheme for the organization ofradiology.
Blumenthalwas aproponentoftheconcentration ofcancerresearchinindependent
institutes because he felt that researchers at other institutes were under no obligation
to work on the cancer problem:'07
The difference between the Universitatsinstitut fuir Krebsforschung at the Charite and all of
these institutes, including the above-mentioned Kaiser Wilhem Institutes [of Biology and of
Biochemistry], is that these institutes could switch to other subjects tomorrow, without any
problem; for them, cancer is only a part of their research task, while the cancer institute is
devoted purely to cancer research.
An important aspect of the present case study is that it shows how a new medical
technique and its proponents had to struggle for a niche within the network oftasks,
instruments and methods ofthe existing forms ofcancer treatment. In this situation,
`SGosta Forssell of the Swedish 106This is an example of how philanthropic
Radiohemmet also perceived such problems as and charitable organizations can influence the
important obstacles for the rational practice of development of cancer control. Cf. David Cantor,
radiotherapy: "The greatest obstacles that have so 'Contracting cancer? The politics of
far stood in the way of cancer therapy have been commissioned histories', Soc. Hist. Med, 1992, 5:
the lack ofprofessionalism in the implementation 131-42.
ofradiotherapy and the fragmentation of its "7Blumenthal to Von Eicken, 28 Feb. 1929;
powers and its weaponry." See Forssell, HUA Med. Fak. 269, 12a.
'Organisation der Krebsbekampfung', in Walther
(ed.), op. cit., note 95 above, p. 57.
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the establishment was formed by surgeons, gynaecologists and internists, while,
according to the formal hierarchy ofGerman medicine, medical clinics and institutes
were governed as if they were independent kingdoms.'08 From these powerful
positions, their managers tried to retain theirjurisdiction over the cancer patient by
claiming competence over the new instruments for radiotherapy.
Those who applied orthodox cancer therapies formulated the problem of the in-
troduction ofthe new cancer intervention technique as ifit were necessary to decide
whichtherapy-surgeryorradiotherapy-wasthemosteffectiveforthecancerpatient.
Thus, to their question, "Scalpel orrays?" theyreplied that surgery was the prime line
ofattack; operation and radiotherapy could best be applied together; and those who
were trained to use the scalpel also controlled the use of the new radiotherapeutic
devices, orat least thatthesecould be used onlyundertheirsupervision. Althoughthe
discussion was presented as concerned with which intervention technique was most
effective, what was actually at stake was the authority overthe cancerpatient.
Thus, the present case study illustrates how a technological innovation was ap-
parently discussed at the technological level, while, at the same time, there was a
struggleforjurisdiction overthenewtechniqueandthecompetence toapplyit. Certain
circumstances which were specific to Germany, i.e. the radium shortage, the lack ofa
tradition of cancer philanthropy, the power of the German medical elite at the uni-
versities andthereluctance oftheGermangovernmenttoplayapartincancercontrol,
meant thatthe development ofradiotherapy took adifferent coursefromthatin other
Europeancountries andthe UnitedStates." Moreover, thiscontributedgreatly to the
factthat cancer research as an independent specialism took longer to establish itselfin
Germany than elsewhere. This situation was not to be reversed until the 1960s.110
108 Stoeckel, op. cit., note 13 above, p. 121. 1 0It was not untii the second half of the
1 On the role of German authorities and 1960s that Karl Heinrich Bauer succeeded in
cancer control, see for instance, Proctor, 'The mobilizing enough support for a German
campaign against tobacco', in idem, The Nazi war National Cancer Institute. See Wagner and
on cancer, op. cit., note 87 above, pp. 173-247. Mauerberger, op. cit., note 8 above.
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